Kim Theilgaard-Mønch

Kim Theilgaard-Mønch

Associate Professor

Primary fields of research

Acute Myeloid Leukemia

Hematopoietic stem cells

Current research

Identification and therapeutic targeting of "oncogenic" signaling and DNA damage response patways in preclinical models of human AML.

Novel antibody-drug conjugate therapy for AML.

Maping of cloncal evolution in AML patients.

Identification of novel human hematopoietic stem cell markers for clinical application  

Fields of interest

Leukemia - therapy/genetics 
Gene regulation
Normal and malignant hematopoietic/myeloid development

ID: 3997971